UPPI Launches Aggressive 2017 Budget

Still savoring a milestone-laden fiscal year 2016, Uni-Pharma management launched an unprecedented, very aggressive and challenging, operational budget for the current year, with revenue growth projection of 60-70%.

This was bared in a general assembly meeting held last December with the members of the board in attendance, together with all employees of the company. “The growth projections will defy the actual performance of the entire market, which is either flat or declining in several therapeutic categories”, said Noel Fortin, Company Managing Director and Head of the Board.

UPPI’s VP for Finance, Alex Duenas, also discussed the various spending areas in relation to sales and exhorted everyone to optimize business opportunities by maximizing sales and managing expenses.

The company’s VP for Supply Chain, Russell Luna, also committed that product importation and procurement will be well managed to ensure continuous availability of stocks to serve increasing demands of customers.

Highlighting the conference was the roll-out of the incentive package which has been totally overhauled to respond to the commitment and effort of the sales teams in bringing about another successful year in terms of target achievement and growth over previous years.

The other members of the management board, Jet Magat, Elmer Opina and Neil Olap, also pledged their share in vigorously sustaining the successful run the company is now experiencing in the industry.